Literature DB >> 25920529

Seroreactivity against Merkel cell polyomavirus and other polyomaviruses in chronic lymphocytic leukaemia, the MCC-Spain study.

Claudia Robles1,2, Delphine Casabonne2,3, Yolanda Benavente2,3, Laura Costas2,3, Eva Gonzalez-Barca4, Marta Aymerich5, Elias Campo5, Adonina Tardon3,6, José J Jiménez-Moleón3,7,8, Gemma Castaño-Vinyals1,3,9,10, Trinidad Dierssen-Sotos3,11, Angelika Michel12, Lena Kranz13, Nuria Aragonés3,14,15, Marina Pollan3,14,15, Manolis Kogevinas16,3,9,1,10, Michael Pawlita13, Silvia de Sanjose2,3.   

Abstract

Merkel cell polyomavirus (MCPyV) has been suspected to cause chronic lymphocytic leukaemia (CLL) but previous data are inconsistent. We measured seroreactivities of nine polyomaviruses (MCPyV, BKPyV, JCPyV, LPyV, KIPyV, WUPyV, HPyV-6, HPyV-7 and TSPyV) in 359 CLL cases and 370 controls using bead-based multiplex serology technology. We additionally tested two herpesviruses (HSV-1 and CMV). Associations between disease and viral seroreactivities were assessed using logistic regression. All human viruses showed high seroprevalences (69-99%) against structural proteins in controls but significantly lower viral seroprevalences in cases (58-94%; OR range = 0.21-0.70, P value < 0.05), except for MCPyV (OR = 0.79, 95% CI = 0.54-1.16). Lower seroreactivity levels were observed among CLL subjects, with significant differences already observed at early stages of disease, unrelated to treatment status. Seroreactivities against polyomavirus related oncoproteins were almost null. Our data suggest no association for MCPyV polyomavirus with CLL development and an unlikely association for other polyomaviruses tested.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25920529     DOI: 10.1099/vir.0.000167

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

Review 1.  Merkel cell polyomavirus and Merkel cell carcinoma.

Authors:  James A DeCaprio
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

2.  A Role of Sp1 Binding Motifs in Basal and Large T-Antigen-Induced Promoter Activities of Human Polyomavirus HPyV9 and Its Variant UF-1.

Authors:  Ugo Moens; Xiaobo Song; Marijke Van Ghelue; John A Lednicky; Bernhard Ehlers
Journal:  Int J Mol Sci       Date:  2017-11-14       Impact factor: 5.923

3.  Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients.

Authors:  Sergi Pascual-Guardia; Michelle Ataya; Isabel Ramírez-Martínez; José Yélamos; Roberto Chalela; Salomé Bellido; Miguel López-Botet; Joaquim Gea
Journal:  Respir Res       Date:  2020-03-04

4.  HPyV6 and HPyV7 in urine from immunocompromised patients.

Authors:  Carla Prezioso; Marijke Van Ghelue; Ugo Moens; Valeria Pietropaolo
Journal:  Virol J       Date:  2021-01-22       Impact factor: 4.099

Review 5.  Functional Domains of the Early Proteins and Experimental and Epidemiological Studies Suggest a Role for the Novel Human Polyomaviruses in Cancer.

Authors:  Ugo Moens; Carla Prezioso; Valeria Pietropaolo
Journal:  Front Microbiol       Date:  2022-02-18       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.